Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ernesto Sparrelid to Bile Duct Neoplasms

This is a "connection" page, showing publications Ernesto Sparrelid has written about Bile Duct Neoplasms.

 
Connection Strength
 
 
 
6.135
 
  1. Jansson H, Taflin H, Björnsson B, Urdzik J, Hemmingsson O, Rystedt JL, Gilg S, Sandström P, Sparrelid E. Outcomes After Resection for Multiple Intrahepatic Cholangiocarcinoma-A National Population-Based Study. Ann Surg Oncol. 2026 Apr; 33(4):2917-2925.
    View in: PubMed
    Score: 0.829
  2. Jansson H, Villard C, Nooijen LE, Ghorbani P, Erdmann JI, Sparrelid E. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2023 04; 49(4):688-699.
    View in: PubMed
    Score: 0.675
  3. Jansson H, Sparrelid E. Letter to the Editor: The Role of Surgery in Multiple Intrahepatic Cholangiocarcinoma Should Not Be Dismissed Without Further Analysis. Hepatology. 2021 10; 74(4):2318-2319.
    View in: PubMed
    Score: 0.612
  4. Jansson H, Cornillet M, Björkström NK, Sturesson C, Sparrelid E. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Eur J Surg Oncol. 2020 05; 46(5):804-810.
    View in: PubMed
    Score: 0.545
  5. Poletto E, Olthof PB, Ruzzenente A, Adam JP, Alwayn IPJ, Boleslawski E, de Boer MT, Chebaro A, Chiche L, Dopazo C, Dubbeld J, Erdmann JI, Hakeem A, Coenraad MJ, Kuipers H, Mabrut JY, Maulat C, Maithel SK, de Meijer VE, Mohkam K, Murad SD, Muscari F, Rolinger J, Polak WG, Rayar M, Ratti F, Robin F, Schnitzbauer AA, Sparrelid E, Van Vilsteren FGI, Porte RJ, Hoogwater FJH, Groot Koerkamp B. Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial Reconstruction. Liver Int. 2026 07; 46(7):e70729.
    View in: PubMed
    Score: 0.214
  6. Luyten JA, Olthof PB, van Kuijk SMJ, Nadalin S, Lang H, Alikhanov R, Erdmann JI, Pratschke J, Maithel SK, Troisi R, Schnitzbauer AA, Sparrelid E, Lodge P, Malagò M, Neumann UP, Schadde E, Malik HZ, Roberts KJ, Topal B, Hoogwater FJH, Hagendoorn J, Ruzzenente A, Gomez C, Jarnagin WR, Cescon M, Aldrighetti L, Koerkamp BG, Dewulf MJL, Olde Damink SWM. Preoperative biliary drainage in perihilar cholangiocarcinoma: retrospective multicentre analysis. BJS Open. 2026 05 12; 10(3).
    View in: PubMed
    Score: 0.212
  7. Huang Y, Santoni G, Sparrelid E, Xie SH. Metformin use and the risk of liver cancer in a Swedish population-based cohort study. JNCI Cancer Spectr. 2026 May 09; 10(3).
    View in: PubMed
    Score: 0.212
  8. Poletto E, Olthof PB, Hoogwater FJH, Erdmann JI, Schnitzbauer AA, Sparrelid E, Maithel SK, Dopazo C, Hakeem AR, Ratti F, Ruzzenente A, Groot Koerkamp B. Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2025 Dec; 32(13):9597-9607.
    View in: PubMed
    Score: 0.203
  9. Akiki A, Jacobsson H, Nouairia G, Cornillet M, Björkström NK, Sparrelid E, Taflin H, Jansson H. External validation of plasma CSF1 as a preoperative prognostic marker in patients with resectable intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2025 08; 51(8):110123.
    View in: PubMed
    Score: 0.198
  10. Olthof PB, Bouwense SAW, Bednarsch J, Dewulf M, Kazemier G, Maithel S, Jarnagin WR, Aldrighetti L, Roberts KJ, Troisi RI, Malago MM, Lang H, Alikhanov R, Ruzzenente A, Malik H, Charco R, Sparrelid E, Pratschke J, Cescon M, Nadalin S, Hagendoorn J, Schadde E, Hoogwater FJH, Schnitzbauer AA, Topal B, Lodge P, Olde Damink SWM, Neumann UP, Groot Koerkamp B. Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort. Ann Surg Oncol. 2025 Mar; 32(3):1762-1768.
    View in: PubMed
    Score: 0.190
  11. Villard C, Widman L, Sparrelid E, Bergquist A, Hagström H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
    View in: PubMed
    Score: 0.190
  12. Reese T, Gilg S, Böcker J, Wagner KC, Vali M, Engstrand J, Kern A, Sturesson C, Oldhafer KJ, Sparrelid E. Impact of the future liver remnant volume before major hepatectomy. Eur J Surg Oncol. 2024 11; 50(11):108660.
    View in: PubMed
    Score: 0.189
  13. Olthof PB, Erdmann JI, Alikhanov R, Charco R, Guglielmi A, Hagendoorn J, Hakeem A, Hoogwater FJH, Jarnagin WR, Kazemier G, Lang H, Maithel SK, Malago M, Malik HZ, Nadalin S, Neumann U, Olde Damink SWM, Pratschke J, Ratti F, Ravaioli M, Roberts KJ, Schadde E, Schnitzbauer AA, Sparrelid E, Topal B, Troisi RI, Groot Koerkamp B. Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible. Ann Surg Oncol. 2024 Jul; 31(7):4405-4412.
    View in: PubMed
    Score: 0.183
  14. Lluís N, Onoe S, Serradilla-Martín M, Achalandabaso M, Mizuno T, Jehaes F, Dasari BVM, Mambrilla-Herrero S, Sparrelid E, Balakrishnan A, Hoogwater FJH, Amaral MJ, Andersson B, Berrevoet F, Doussot A, López-López V, Detry O, Pozo CD, Machairas N, Pekli D, Alcázar-López CF, Asbun H, Björnsson B, Christophides T, Díez-Caballero A, Francart D, Noel CB, Sousa-Silva D, Toledo-Martínez E, Tzimas GN, Yaqub S, Yamaguchi J, Dokmak S, Prieto-Calvo M, D'Souza MA, Spiers HVM, van den Heuvel MC, Charco R, Lesurtel M, Ebata T, Ramia JM. Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan. HPB (Oxford). 2024 04; 26(4):565-575.
    View in: PubMed
    Score: 0.181
  15. Ratti F, Marino R, Olthof PB, Pratschke J, Erdmann JI, Neumann UP, Prasad R, Jarnagin WR, Schnitzbauer AA, Cescon M, Guglielmi A, Lang H, Nadalin S, Topal B, Maithel SK, Hoogwater FJH, Alikhanov R, Troisi R, Sparrelid E, Roberts KJ, Malagò M, Hagendoorn J, Malik HZ, Olde Damink SWM, Kazemier G, Schadde E, Charco R, de Reuver PR, Groot Koerkamp B, Aldrighetti L. Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. Hepatology. 2024 02 01; 79(2):341-354.
    View in: PubMed
    Score: 0.175
  16. Ratti F, Marino R, Muiesan P, Zieniewicz K, Van Gulik T, Guglielmi A, Marques HP, Andres V, Schnitzbauer A, Irinel P, Schmelzle M, Sparrelid E, Fusai GK, Adam R, Cillo U, Lang H, Oldhafer K, Ruslan A, Ciria R, Ferrero A, Mazzaferro V, Cescon M, Giuliante F, Nadalin S, Golse N, Sulpice L, Serrablo A, Ramos E, Marchese U, Rosok B, Lopez-Lopez V, Clavien P, Aldrighetti L. Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma. HPB (Oxford). 2023 Nov; 25(11):1302-1322.
    View in: PubMed
    Score: 0.175
  17. Lluís N, Serradilla-Martín M, Achalandabaso M, Jehaes F, Dasari BVM, Mambrilla-Herrero S, Sparrelid E, Balakrishnan A, Hoogwater FJH, Amaral MJ, Andersson B, Berrevoet F, Doussot A, López-López V, Alsammani M, Detry O, Domingo-Del Pozo C, Machairas N, Pekli D, Alcázar-López CF, Asbun H, Björnsson B, Christophides T, Díez-Caballero A, Francart D, Noel CB, Sousa-Silva D, Toledo-Martínez E, Tzimas GN, Yaqub S, Cauchy F, Prieto-Calvo M, D'Souza MA, Spiers HVM, van den Heuvel MC, Charco R, Lesurtel M, Ramia JM. Intraductal papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study). Int J Surg. 2023 Apr 01; 109(4):760-771.
    View in: PubMed
    Score: 0.171
  18. Zimmer CL, Filipovic I, Cornillet M, O'Rourke CJ, Berglin L, Jansson H, Sun D, Strauss O, Hertwig L, Johansson H, von Seth E, Sparrelid E, Dias J, Glaumann H, Melum E, Ellis EC, Sandberg JK, Andersen JB, Bergquist A, Björkström NK. Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma. Hepatology. 2022 05; 75(5):1154-1168.
    View in: PubMed
    Score: 0.157
  19. D'Souza MA, Al-Saffar HA, Fernández Moro C, Shtembari S, Danielsson O, Sparrelid E, Sturesson C. Redefining resection margins and dissection planes in perihilar cholangiocarcinoma-radical resection is a rare event. Virchows Arch. 2022 Mar; 480(3):557-564.
    View in: PubMed
    Score: 0.156
  20. Ruzzenente A, Bagante F, Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Koerkamp BG, Jarnagin WR, Nadalin S, Pratschke J, Schmelzle M, Sparrelid E, Lang H, Iacono C, van Gulik TM, Guglielmi A. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group. Ann Surg Oncol. 2021 Nov; 28(12):7719-7729.
    View in: PubMed
    Score: 0.150
  21. Jansson H, Olthof PB, Bergquist A, Ligthart MAP, Nadalin S, Troisi RI, Groot Koerkamp B, Alikhanov R, Lang H, Guglielmi A, Cescon M, Jarnagin WR, Aldrighetti L, van Gulik TM, Sparrelid E. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study. HPB (Oxford). 2021 11; 23(11):1751-1758.
    View in: PubMed
    Score: 0.150
  22. Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2020 Jul; 27(7):2311-2318.
    View in: PubMed
    Score: 0.138
  23. Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Björkström NK. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Gastroenterology. 2019 10; 157(4):1067-1080.e9.
    View in: PubMed
    Score: 0.132
  24. Huang Y, Santoni G, Petrick JL, Wocalewski V, Sparrelid E, Xie SH. Menopausal hormone therapy and risk of liver cancer in a Swedish population-based cohort study. J Natl Cancer Inst. 2026 Aug 01; 118(8):1478-1484.
    View in: PubMed
    Score: 0.054
  25. Uijterwijk BA, Lemmers DH, Fusai GK, Zerbi A, Salvia R, Sparrelid E, White S, Björnsson B, Mavroeidis VK, Roberts KJ, Mazzola M, Cabús SS, Soonawalla Z, Korkolis D, Serradilla M, Pessaux P, Luyer M, Mowbray N, Ielpo B, Mazzotta A, Kleeff J, Boggi U, Muñoz MAS, Goh BKP, Andreotti E, Wilmink H, Ghidini M, Zaniboni A, Verbeke C, Adsay V, Bianchi D, Besselink MG, Abu Hilal M. Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review. Ann Surg Oncol. 2024 Jul; 31(7):4654-4664.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)